Anti-GM1 antibodies affect the integrity of lipid rafts

Molecular and Cellular Neuroscience

Volumn 45, Issue 4, 2010, Pages 355-362

  Ueda, Akihiro ^a   Shima, Sayuri ^a   Miyashita, Tadayuki ^a   Ito, Shinji ^a   Ueda, Masami ^b   Kusunoki, Susumu ^b   Asakura, Kunihiko ^a   Mutoh, Tatsuro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GM1 antibody; Guillain Barr syndrome; Lipid rafts; Nerve growth factor; Trk neurotrophin receptor

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID RAFT; MALE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ADULT; AGED; ANIMALS; AUTOANTIBODIES; BLOTTING, WESTERN; CELL LINE; FEMALE; G(M1) GANGLIOSIDE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOPRECIPITATION; MALE; MEMBRANE MICRODOMAINS; MIDDLE AGED; NERVE GROWTH FACTOR; PC12 CELLS; PHOSPHORYLATION; RATS; RECEPTOR, TRKA; YOUNG ADULT;

EID: 77957955083     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.07.008     Document Type: Article

References (25)

1. Cordon-Cardo C., Tapley P., Jing S., Nanduri V., O'Rourke E., Lamballe F., Korary K., Klein R., Jones K.R., Reichchardt L.F. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 1991, 66:173-183.
2. Cuello A.C., Garofalo L., Keningsberg R.L., Mayasiger D. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc. Natl Acad. Sci. USA 1989, 86:2056-2060.
3. Doherty P., Dickson J.G., Flanigan T.P., Walsh F.S. Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurones. J. Neurochem. 1985, 44:1259-1265.
4. Farooqui T., Franklin T., Peral D.K., Yates A.J. Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J. Neurochem. 1997, 68:2348-2455.
5. Feasby T.E., Gulbert J.J., Brown W.F., Bolton C.F., Hahn A.D., Koopaman W.F., et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain 1986, 109:1115-1126.
6. Ferrari G., Fabris M., Gorio A. Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res. 1983, 513:286-294.
7. Hadden R.D.M., Cornblath D.R., Hughes R.A., et al. Electrophysiological classification of Gulillain-Barré syndrome: clinical associations and outcome: plasma exchange/sandoglobulin. Guillain-Barré syndrome Trial Group. Ann. Neurol. 1998, 44:780-787.
8. Hughes R.A.C., Hadden R.D.M., Gregson N.A., Smith K.J. Pathogenesis of Gulillain-Barré syndrome. J. Neuroimmunol. 1999, 100:74-97.
9. Kaida K., Kusunoki S., Kamakura K., Motoyoshi K., Kanazawa I. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 2000, 123:116-124.
10. Kaida K., Sonoo M., Ogawa G., Kamakura K., Ueda-Sada M., Arita M., Motoyoshi K., Kusunoki S. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndrome. Neurology 2008, 71:1683-1690.
11. Kaplan D.R., Martin-Zanca D., Parada L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991, 350:158-160.
12. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991, 252:554-558.
13. Katoh-Semba R., Skaper S.D., Varon S. Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum- and NGF-dependent effects on neuritic growth (and proliferation). J. Neurosci. Res. 1984, 12:293-310.
14. Kusunoki S., Iwamori M., Chiba A., Hiroshi S., Arita M., Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 1996, 47:237-242.
15. Loeb D.M., Greene L.A. Transfection with trk restores "slow" NGF binding, efficient NGF uptake, and multiple NGF responses to NGF-nonresponsive PC12 cell mutants. J. Neurosci. 1993, 13:2919-2929.
16. Mutoh T., Tokuda A., Guroff G., Fujiki N. The effects of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells. J. Neurochem. 1993, 60:1540-1547.
17. Mutoh T., Tokuda A., Miyadai T., Hamaguchi M., Fujiki N. Ganglioside GM1 binds to the Trk protein and regulate receptor function. Proc. Natl Acad. Sci. USA 1995, 92:5087-5091.
18. Mutoh T., Tokuda A., Inokuchi J., Kuriyama M. Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells. J. Biol. Chem. 1998, 273:26001-26007.
19. Mutoh T., Hamano T., Tokuda A., Kuriyama M. Unglycosylated Trk protein does not co-localize nor associate with gangliosides GM1 in stable clone overexpressing Trk of PC12 cells (PCtrk). Glycoconj. J. 2000, 17:233-237.
20. Mutoh T., Hamano T., Yano S., Koga H., Yamamoto H., Furukawa K., Ledeen R.W. Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem. Res. 2002, 27:801-806.
21. O'Hanlon G.M., Hirst T.R., Willison H.J. Ganglioside GM1 biding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay. Neurosci. Res. 2003, 47:383-390.
22. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
23. Tanaka T., Furutama D., Saki R., Fujita A., Kimura F., Tagami M., Ohsawa N., Hanafusa T. Biological roles of anti-GM1 antibodies in patients with Guillain-Barre syndrome for nerve growth factor signaling. Biochim. Biophys. Acta 2007, 1772:543-548.
24. Visser L.H., Van der Meche F.G., Van Doorn P.A., et al. Guillain-Barre syndrome with sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnositic and laboratory features: Dutch Guillain-Barré study group. Brain 1995, 118:841-847.
25. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125:2591-2625.